Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

The Effectiveness and Efficacy of the Combination of Pharmacotherapy With the Two New Recovery-oriented Programs, RECOVERYTRSGR (Treatment Resistant Schizophrenia) and RECOVERYTRSBDGR (Treatment Resistant Bipolar Disorder)

The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.

RECOVERYTRSGR is a newly developed program for patients with treatment resistant schizophrenia by Dr. S. Rakitzi and Dr. P. Georgila. RECOVERYTRSBDGR is a newly developed program for patients with treatment resistant bipolar disorder by Dr. S. Rakitzi and Dr. P. Georgila. These programs offer a long term combination of pharmacotherapy and cognitive behavioral psychotherapy and rehabilitation and aim to imrove cognition, symptoms, functional outcomes and recovery.

Treatment resistant schizophrenia and treatment resistant bipolar disorder are the most difficult chronic mental health disorders which need long-term treatment.

Inclusion Criteria: For patients with treatment resistant schizophrenia:

• age 18-65
• IQ ≥ 80
• Diagnosis TRS.

Inclusion criteria for patients with treatment resistant bipolar disorder:

• age 18-65
• IQ ≥ 80
• Diagnosis TRSBD.

Exclusion Criteria: For patients with treatment resistant schizophrenia:

• Substance abuse and head injury. If substance abuse is successfully treated, the participant will be accepted into our program.
• Relapse and hospitalization.

Exclusion criteria for patients with treatment resistant bipolar diosrder:

• Substance abuse and head injuries. If substance abuse is successfully treated, the participant will be acknowledged into our program.
• Relapse and hospitalization.